78
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation

, &
Pages 1101-1109 | Published online: 06 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maurizio Rossini, Giovanni Adami, Silvano Adami, Ombretta Viapiana & Davide Gatti. (2016) Safety issues and adverse reactions with osteoporosis management. Expert Opinion on Drug Safety 15:3, pages 321-332.
Read now

Articles from other publishers (1)

Rui Niimi, Toshibumi Kono, Atsushi Nishihara, Masahiro Hasegawa, Toshihiko Kono & Akihiro Sudo. (2016) The Relationship of BMD Increases Between the First 12 Months and the Latter 12 Months by Daily Teriparatide Treatment. Calcified Tissue International 99:3, pages 282-288.
Crossref